JP2008540628A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540628A5 JP2008540628A5 JP2008511798A JP2008511798A JP2008540628A5 JP 2008540628 A5 JP2008540628 A5 JP 2008540628A5 JP 2008511798 A JP2008511798 A JP 2008511798A JP 2008511798 A JP2008511798 A JP 2008511798A JP 2008540628 A5 JP2008540628 A5 JP 2008540628A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- alkyl
- hydroxyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000005843 halogen group Chemical group 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 150000001412 amines Chemical class 0.000 claims 2
- -1 amino, hydroxyl Chemical group 0.000 claims 2
- 150000002009 diols Chemical class 0.000 claims 2
- 239000002798 polar solvent Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 150000003212 purines Chemical class 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical class C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000006575 electron-withdrawing group Chemical group 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229960004396 famciclovir Drugs 0.000 claims 1
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 238000005984 hydrogenation reaction Methods 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 claims 1
- 0 *CC(C*)*[n]1c2nc(*)ncc2nc1 Chemical compound *CC(C*)*[n]1c2nc(*)ncc2nc1 0.000 description 6
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0510345A GB2426247A (en) | 2005-05-20 | 2005-05-20 | Methods of preparing purine derivatives such as famciclovir |
| GB0510345.2 | 2005-05-20 | ||
| PCT/GB2006/001877 WO2006123175A1 (en) | 2005-05-20 | 2006-05-19 | Preparation of famciclovir and other purine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008540628A JP2008540628A (ja) | 2008-11-20 |
| JP2008540628A5 true JP2008540628A5 (enExample) | 2009-04-30 |
| JP5227166B2 JP5227166B2 (ja) | 2013-07-03 |
Family
ID=34834391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008511798A Expired - Fee Related JP5227166B2 (ja) | 2005-05-20 | 2006-05-19 | ファムシクロビルおよび他のプリン誘導体の調製 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7601835B2 (enExample) |
| EP (1) | EP1883639B1 (enExample) |
| JP (1) | JP5227166B2 (enExample) |
| CN (1) | CN101233134B (enExample) |
| AT (1) | ATE479688T1 (enExample) |
| AU (1) | AU2006248745B2 (enExample) |
| BR (1) | BRPI0609632A2 (enExample) |
| CA (1) | CA2608490C (enExample) |
| DE (1) | DE602006016593D1 (enExample) |
| DK (1) | DK1883639T3 (enExample) |
| ES (1) | ES2351925T3 (enExample) |
| GB (1) | GB2426247A (enExample) |
| NZ (1) | NZ563636A (enExample) |
| PL (1) | PL1883639T3 (enExample) |
| PT (1) | PT1883639E (enExample) |
| TW (1) | TW200716638A (enExample) |
| WO (1) | WO2006123175A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040097528A1 (en) * | 2002-08-26 | 2004-05-20 | Ben-Zion Dolitzky | Crystalline solid famciclovir forms I, II, III and preparation thereof |
| WO2004099208A1 (en) * | 2003-04-30 | 2004-11-18 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of famciclovir |
| KR20080091298A (ko) * | 2004-05-18 | 2008-10-09 | 테바 파마슈티컬 인더스트리즈 리미티드 | 결정성 고체 팜시클로버의 제조를 위한 건조방법 |
| WO2008072074A1 (en) * | 2006-12-11 | 2008-06-19 | Aurobindo Pharma Limited | An improved process for the preparation of purine derivative |
| CN101555249B (zh) * | 2008-04-08 | 2011-05-11 | 浙江海正药业股份有限公司 | 泛昔洛韦的合成方法 |
| CN102924455A (zh) * | 2011-08-11 | 2013-02-13 | 重庆圣华曦药业股份有限公司 | 一种泛昔洛韦中间体的合成方法 |
| CN104496991A (zh) * | 2014-11-04 | 2015-04-08 | 常州康丽制药有限公司 | 高品质2-氨基-6-氯-9-(4-羟基-3–羟甲基丁基)嘌呤的制备方法 |
| CN104744472A (zh) * | 2015-03-12 | 2015-07-01 | 常州康丽制药有限公司 | 高品质2-氨基-6-氯-9-(4-羟基-3-羟甲基丁基)嘌呤的制备方法 |
| CN109456329B (zh) * | 2018-11-19 | 2021-03-09 | 迪嘉药业集团有限公司 | 一种泛昔洛韦的制备方法 |
| CN114787129B (zh) | 2019-12-11 | 2025-07-04 | 塔罗制药工业有限公司 | 曲法罗汀及其中间体和多晶型物的制备 |
| CN112979653A (zh) * | 2019-12-12 | 2021-06-18 | 上药康丽(常州)药业有限公司 | 一种利用微通道反应器合成泛昔洛韦的方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3485225D1 (de) * | 1983-08-18 | 1991-12-05 | Beecham Group Plc | Antivirale guanin-derivate. |
| US5684153A (en) | 1984-08-16 | 1997-11-04 | Beecham Group Plc | Process for the preparation of purine derivatives |
| EP0182024B1 (en) * | 1984-09-20 | 1991-04-03 | Beecham Group Plc | Purine derivatives and their pharmaceutical use |
| SE8406538D0 (sv) | 1984-12-21 | 1984-12-21 | Astra Laekemedel Ab | Novel derivatives of purine |
| GB8817607D0 (en) * | 1988-07-23 | 1988-09-01 | Beecham Group Plc | Novel process |
| GB8822236D0 (en) | 1988-09-21 | 1988-10-26 | Beecham Group Plc | Chemical process |
| GB9402161D0 (en) | 1994-02-04 | 1994-03-30 | Wellcome Found | Chloropyrimidine intermediates |
| GB9407698D0 (en) * | 1994-04-19 | 1994-06-15 | Smithkline Beecham Plc | Pharmaceuticals |
| JPH11180983A (ja) | 1997-12-24 | 1999-07-06 | Sumika Fine Chemicals Co Ltd | 9置換2−アミノ−6−ハロゲノプリンおよびその製法 |
| GB9807116D0 (en) * | 1998-04-02 | 1998-06-03 | Smithkline Beecham Plc | Novel process |
| GB9807114D0 (en) * | 1998-04-02 | 1998-06-03 | Smithkline Beecham Plc | Novel process |
| SI20022A (sl) * | 1998-07-29 | 2000-02-29 | Kemijski inštitut | Alkilno substituirani purinovi derivati in njihova priprava |
| DE60202245T2 (de) | 2001-08-30 | 2005-09-01 | Ajinomoto Co., Inc. | Herstellungsmethode von Famciclovir und Herstellungs- bzw. Kristallisationsmethode eines entsprechenden Intermediates |
| JP2003146988A (ja) * | 2001-08-30 | 2003-05-21 | Ajinomoto Co Inc | ファムシクロビルの製造方法、並びにその中間体の製造および晶析方法 |
| KR100573860B1 (ko) | 2003-06-13 | 2006-04-25 | 경동제약 주식회사 | 2-아미노-9-(2-치환에틸)푸린을 이용한 9-[4-아세톡시-3-(아세톡시메틸)부트-1-일]-2-아미노푸린의 제조방법 |
| US20050215787A1 (en) * | 2004-03-26 | 2005-09-29 | Joshi Ramesh A | An improved process for the preparation of purines |
-
2005
- 2005-05-20 GB GB0510345A patent/GB2426247A/en not_active Withdrawn
- 2005-11-10 US US11/270,777 patent/US7601835B2/en not_active Expired - Fee Related
-
2006
- 2006-05-19 BR BRPI0609632-8A patent/BRPI0609632A2/pt not_active IP Right Cessation
- 2006-05-19 PT PT06743955T patent/PT1883639E/pt unknown
- 2006-05-19 EP EP06743955A patent/EP1883639B1/en not_active Not-in-force
- 2006-05-19 TW TW095117840A patent/TW200716638A/zh unknown
- 2006-05-19 WO PCT/GB2006/001877 patent/WO2006123175A1/en not_active Ceased
- 2006-05-19 PL PL06743955T patent/PL1883639T3/pl unknown
- 2006-05-19 DE DE602006016593T patent/DE602006016593D1/de active Active
- 2006-05-19 CN CN200680017571XA patent/CN101233134B/zh not_active Expired - Fee Related
- 2006-05-19 AT AT06743955T patent/ATE479688T1/de active
- 2006-05-19 CA CA2608490A patent/CA2608490C/en not_active Expired - Fee Related
- 2006-05-19 AU AU2006248745A patent/AU2006248745B2/en not_active Ceased
- 2006-05-19 ES ES06743955T patent/ES2351925T3/es active Active
- 2006-05-19 NZ NZ563636A patent/NZ563636A/en not_active IP Right Cessation
- 2006-05-19 DK DK06743955.4T patent/DK1883639T3/da active
- 2006-05-19 JP JP2008511798A patent/JP5227166B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010532340A5 (enExample) | ||
| ES2746801T3 (es) | Proceso de preparación de agonistas beta-3 y productos intermedios | |
| JP2008540628A5 (enExample) | ||
| IL175024A0 (en) | Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters | |
| CA2657483A1 (en) | Macrolide synthesis process | |
| WO2007031548A3 (en) | Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof | |
| JP2009298770A5 (enExample) | ||
| JP2010532365A5 (enExample) | ||
| JP2010529994A5 (enExample) | ||
| RU2012122367A (ru) | Способ получения простагландинов и промежуточные соединения для их получения | |
| JP2008286881A5 (enExample) | ||
| JP2018502174A5 (enExample) | ||
| JP2013521224A5 (enExample) | ||
| Das et al. | Stereoselective direct reductive amination of ketones with electron-deficient amines using Re 2 O 7/NaPF 6 catalyst | |
| JP2011502147A5 (enExample) | ||
| WO2007049295B1 (en) | An improved one pot process for making key intermediate for gemcitabine hcl | |
| JP2007045816A5 (ja) | カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法 | |
| WO2008053496A4 (en) | An improved process for the manufacture of cis (-)-lamivudine | |
| JP6228210B2 (ja) | フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法 | |
| WO2020183295A1 (en) | Process for preparation of tofacitinib and pharmaceutically acceptable salt thereof | |
| JP2007210969A5 (enExample) | ||
| BRPI0616169B8 (pt) | cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina | |
| EP2917192A2 (en) | Process for the preparation of cabazitaxel and its intermediates | |
| JP2011503175A5 (enExample) | ||
| JP2004503519A5 (enExample) |